Global Adult Vaccine Industry is projected to grow with a CAGR of 6% from 2021-2027

According to Renub Research report titled, “Adult Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Adult Vaccine Market is estimated to reach USD 18.8 Billion by 2021. Over the years, vaccine-preventable diseases have been killing thousands of adults each year worldwide. Vaccines, surprisingly, are used to prevent infections and boost the body’s immunity. Hence, adult vaccination has become one of the most cost-effective public health interventions accessible today. Moreover, it is also a biological preparation that comprises an agent that looks like a disease-causing germ created from weakened and destroyed microorganisms.

Global Adult Vaccine Market to Reach US$ 26.7 Billion by 2027

Global Adult Vaccine Industry Is Projected to Grow with A CAGR of 6% From 2021-2027:

Some of the major drivers for the global adult vaccines market are increased illness prevalence and novel vaccination technologies. Furthermore, increased research in the field of vaccine technology and increasing government backing are all contributing to the global adult vaccines market’s growth. Several government agencies are funding and granting research on customized vaccinations to improve their efficacy and disease-prevention potential.

In addition, some government organizations are putting in place particular requirements for their safe practices. Increased R&D investment by pharmaceutical and biopharmaceutical companies and widespread R&D pipelines are expected to help move the worldwide adult vaccines market forward.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Disease wise – Adult Vaccines Market & Numbers of Adults Vaccinated:

In our report, Coronavirus (COVID-19), Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, and Varicella are the diseases included. Furthermore, due to the growing negative worries about prevalent infectious diseases, which are the leading causes of mortality and morbidity worldwide, the number of immunizations for various diseases is at an all-time high.

Further, the worldwide number of adult vaccines vertical has seen significant expansion due to the continual increase in demand for immunization against severe diseases such as cholera, typhoid, hepatitis, measles, chickenpox, and many others. On the other hand, several molecular entities are through substantial research and development stages and are aimed at immunizing against deadly diseases.

Key Players in the Global Adult Vaccine Industry:

The significant companies studied in the global adult vaccine market include GlaxoSmithKline, plc, Merck & Co.’s, Sanofi Pasteur’s, Pfizer, Inc.’s, and Thoracic Aortic Aneurysm (TAA) CSL Limited’s. As per our analysis, the key players are focusing on business expansion to increase their revenue share by implementing mergers and acquisitions and new product development strategies. For instance, GlaxoSmithKline plc announced in 2021 that they had submitted a (BLA) Biologics License Application to the US Food and Drug Administration for their investigational vaccine PRIORIX, requesting authorization to use it against measles, mumps, and rubella (MMR) in the United States. The vaccine was first registered in Germany and is now approved in more than 100 countries worldwide.

COVID-19’s Impact on the Global Adult Vaccine Market:

The COVID-19 pandemic had a diverse impact on the global adult vaccine industry. Vaccination rates for some vaccines have decreased. On the other hand, vaccination rates for a few vaccines, such as flu vaccines, have increased. The introduction of COVID-19 vaccines has significantly impacted the vaccine industry’s overall growth. Furthermore, we aim to see the global adult vaccines market to quantify the health, economic, and social benefits of vaccines and immunization programs to individuals and society.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Market Summary:

  • Disease Wise: We have analysed the market for Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel and Miscellaneous, Varicella)
  • Numbers of Vaccinated Adults: We have covered the numbers of vaccinated adults for Influenza, Meningococcal, Cervical Cancer (HPV), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Zoster (Shingles), Hepatitis, TdaP, Varicella.
  • Company Analysis: The key players covered in our report are GlaxoSmithKline, plc., Merck & Co., Sanofi Pasteur’s, Pfizer, Inc., Thoracic Aortic Aneurysm (TAA) CSL Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Anesthesia Drugs Market will grow with a CAGR of 4% from 2021-2027

As per the latest report by Renub Research titled “United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” United States Anesthesia Drugs Market Size was US$ 4.9 Billion by 2027. In the United States, anesthesia drug is one of the milestones in the pharmaceutical industry, which benefits patients with painless treatment and impossible to perform surgery. The US is home to bigwigs in the pharmaceutical sector to increase their stakes in the United States market. Anesthesia meant the condition of holding sensation blocked or temporarily taken away. This authorizes the patient to undergo surgery and other procedures without distress and pain they would otherwise experience. Anesthesia drugs are used while performing surgical procedures to control pain, heart rate, blood pressure, breathing, rhythm, and blood flow.

Top Impacting Factors:

Notwithstanding, the United States anesthesia drug market is driven by the rising number of surgeries, the growing aging population with increasing chronic conditions, and advancements in anesthesia technologies. As per the statistics provided by the (ASPS) American Society of Plastic Surgeons, in 2019, nearly 16.3 Million cosmetic minimally-invasive procedures and 1.8 Million cosmetic surgical were performed in the United States.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=united-states-anesthesia-drugs-market-and-forecast-31-p.php

Furthermore, the demand for various anesthetics goes hand-in-hand with the performed surgical procedures. The application of anesthetics in general surgeries is anticipated to contribute significantly to the market’s growth in the United States. Further, new anesthesia drugs are being developed, which is predicted to propel market growth. For instance, in 2020, Medova and the New York School of Regional Anesthesia (NYSORA) entered a partnership to introduce SAFIRA (SAFer Injection for Regional Anesthesia) in the United States.

COVID-19 Impact on Anesthesia Drugs Industry:

In the United States, the demand for anesthesia drugs seen a slight drop in 2020 due to the emergence of the pandemic situation, cancelled surgeries or leading to delayed. With the emergence of COVID-19, the United States faced extreme shortages of vital anesthesia drugs, mainly canceled surgeries, dexmedetomidine, midazolam, Propofol, and neuromuscular blocking agents. Most of the surgeries were delayed, and only acute surgical emergencies were managed. Thus, the COVID-19 has an unfavorable impact on the United States anesthesia drugs industry. As a result, numerous players are ramping up their production of anesthesia drugs. For instance, in 2020, Hikma Pharmaceutical introduced a new product, “Propofol Injectable Emulsion,” in the United States.

General Inhalation Anesthesia is the Leading Segments in the United States Anesthesia Market

Based on type, the United States anesthesia drugs market includes the General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market, and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds a considerable market share; the inhaled anesthetics include desflurane, isoflurane, sevoflurane, and others that enhance inhibit excitatory synaptic activity and inhibitory postsynaptic channel activity. General intravenous anesthesia drugs are less costly and do not need expensive machines for administration. Moreover, intravenous anesthesia drugs result in undersized cardiovascular depression and better postoperative analgesia.

Besides, general intravenous anesthesia is the leading segment in the United States Anesthesia Market. Fospropofol Disodium, Propofol, Benzodiazepines Class, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, and Fentanyl are generally utilized general intravenous anesthesia in the United States. Propofol drug is one of the most frequently used general anesthetics in surgeries among these anesthesia drugs. It is utilized as a sedative for critical care (including COVID-19) in the ICU. It is used to maintain procedural sedation, initiate general anesthesia, etc. In  2020, the United States (FDA) Food & Drug Administration approved the usage of Fresenius Propoven 2% emulsion to maintain sedation in COVID-19 patients (16 years and above) requiring mechanical ventilation.

Competitive Landascape

The United States anesthesia drugs market is highly competitive and consists of several major players. Most of the anesthesia drugs trade is generic and are available at a low cost. The key players include Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-anesthesia-drugs-market-and-forecast-31-p.php

Market Summary:

  • Types – Renub Research Report covers United States Anesthesia Drugs Market by type in the 3 viewpoints (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market)
  • United States Anesthesia Drugs Market – This has been further break-up in 8 segments: Propofol, Benzodiazepines Class (Diazepam and Midazolam), Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, Fentanyl
  • United States General Inhalation Anesthesia Drugs Market – This has been further break-up in 4 segments: Sevoflurane, Desflurane,   Isoflurane, Others
  • United States Local Anesthesia Drugs Market – This has been further break-up in 7 segments: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other Local Anesthetics
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Endoscopy Devices Market is expected to grow at a CAGR of 7.19% from 2021 to 2027

According to the latest report by Renub Research, “United States Endoscopy Devices Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the United States Endoscopy Devices Market Size is projected to reach US$ 27.9 Billion by 2027. Endoscopy devices are thin and long tubes inserted inside the body via mouth or incision to examine the interior of the bladder, stomach, ears, nose, esophagus, colon, throat, heart, joints, urinary tract, and abdomen. These tubes have a light source attached and a camera, which help healthcare professionals to perform laparoscopic and biopsies and arthroscopy surgeries. They are available in various lengths and flexibilities depending on diagnostic organs.

United States Endoscopy Devices Market to Grow with a CAGR of 7.19% from 2021 to 2027

United States Endoscopy Devices Market Size was US$ 18.8 Billion in 2021

The change in the trend of adoption from traditional open surgeries to minimally invasive techniques by healthcare professionals and patients is one of the primary factors growing the endoscopy devices market in the United States. Other factors promoting growth include the rising prevalence of chronic conditions, the increasing geriatric population, and technological advancements in endoscopy devices.

Moreover, the increasing number of neurological disorders and the rising adoption of minimally invasive surgeries attributed to the United States endoscopic devices market growth. As per ONP hospitals statistics, the United States contributes to 32% of the number, i.e., around 4,800,000 laparoscopic procedures are performed every year. This implies that endoscopic procedures are performed widely in the country.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-endoscopy-devices-market-p.php

Endoscopy Visualization Components product dominates the United States Endoscopy Devices Market

Depending on the product, the global endoscopy devices market is divided into Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems, and Endoscopes. The endoscopy visualization components register a significant dominance in the United States endoscopy devices industry. This is attributable to benefits provided by high-definition visualization systems for treating and diagnosing complex health conditions such as cancer, urinary disorders, GI disorders, and lung disorders and increasing preference of healthcare professionals towards utilizing endoscopy visualization systems for better diagnosis and treatment.

In United States G.I. Tumors accounts for the Second Highest Cause of cancer-related Deaths

In the United States, endoscopy sub-products like robot-assisted endoscopes, capsule endoscopes, and rigid endoscopes are widely used in various medical specialties applications, such as gastroenterology, urology, gynecology, pulmonology ENT, and others. The increasing burden of G.I. disorders, coupled with the growing geriatric population, is propelling the demand for Gastroenterology Endoscopy. G.I. tumors are the second most extensive cause of cancer-related deaths in the United States. Thus, an upsurge in endoscopic procedures for the early diagnosis of G.I. cancers offers considerable revenue opportunities.

Bariatric Surgery Drives the Capsule Endoscopy Market Growth

Although, sub-product Capsule endoscopy is widely used to detect minor bowel damage, Crohn’s disease, obscure intestinal bleeding, etc., in the United States. Capsule endoscopy has significant benefits for patients with small bowel disease for whom the proper diagnosis is not available. In addition, the capsule endoscope is on-demand due to its cost-effectiveness. Moreover, many surgical procedures using endoscopic procedures such as bariatric surgery boost the Capsule endoscopy market growth in the United States.

Besides, the market comprises both hospitals and ambulatory surgery centers/clinics by end-users. Nevertheless, in the United States, hospitals have emerged as the most primary health system. Thus, the number of endoscopic surgeries done at hospitals is relatively more than the other health systems, such as specialty clinics or Ambulatory Surgical Centers (ASCs).

COVID- 19 Impact on the United States Endoscopy Devices Industry:

COVID-19 is an incomparable global public health emergency that has affected the United States in almost every industry, including the endoscopy device industry. The primary cause for the decline in endoscopy procedures during the COVID-19 pandemic was decreased patient volume in hospitals due to delaying guidelines for safety reasons and rescheduling. Moreover, these delays happened after careful review of patient history, and healthcare providers rescheduled endoscopic procedures to minimize the chance of exposure to COVID-19 during hospital visits.

Competitive Landscape:

The United States endoscopy devices industry is highly competitive, and prominent players have adopted various strategies to increase their endoscopy devices market share. These include product launch, product development, product approval, and acquisition. Major US endoscopy devices market players include Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker, and Conmed.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-endoscopy-devices-market-p.php

Market Summary:

  • Product – We have covered United States Endoscopy Device Market breakup by 4 viewpoints by-product (Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems and Endoscopes)
  • Sub-Product – Renub Research Report covers by Sub-Product in the 5 viewpoints (Rigid Endoscopes, Robot Assisted Endoscopes, Disposable Endoscopes, Capsule Endoscopes and Flexible Endoscopes)
  • Application – Our Report has covered United States Endoscopy Device Market breakup by 6 Application (Gastroenterology, ENT Surgery, Gynecology, Neurology, Urology and Other Applications)
  • End Users – This Report covers by End Users in the 3 viewpoints (Hospitals, Ambulatory Surgery Centers/Clinics and Other End Uses)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker and Conmed.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

China Dental Market to Grow at double digit CAGR of 15.91% from 2021 – 2026

According to the latest report by Renub Research, titled “China Dental Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast” the China Dental Market will reach US$ 17.7 Billion by 2026. For a long time, the oral disease has been one of the major problems of public health for its high prevalence and incidence throughout China, which is especially true for middle and low-income populations. According to the National Oral Health Epidemiological, 31.9% of 5-year-old children and 40% of 12-year-old children brush their teeth twice a day. 43.2% of both sections visit dentists for prevention of oral diseases, consultation and examination. Lastly, 36.1% of adults brush their teeth twice a day; these changes have a significant impact on China dental market.


As there is growth in living standards due to rise in disposable income, the need for dental services led to a burgeoning dental market in China. Mounting perception of the importance of oral hygiene, i.e. having the mouth and teeth clean; and can stop cavities, gingivitis (inflammation of the gums), and bad breath, is one of the major factors which helps to reach the China dental market to its new glory in the coming future. Besides, per capita expenditure on healthcare services is improving and demand for specialist dental hospitals in China is growing significantly. In 2021 as per Statista, there were around 535 hospitals specialized in dental treatments in the country’s urban areas, whereas 154 dental hospitals remained in rural areas in China.

China Dental Market to Grow at double digit CAGR of 15.91% from 2021 – 2026


Public knowledge of oral hygiene has improved, giving the sector excellent growth potential in Shanghai, Beijing, and Guangzhou. Therefore, across different regions in China, the dental industry has been incorporated as an essential aspect of healthcare. The segment authorizes doctors to realize multi-site licenses and unrestricted licenses in the most accessible manner.

China Dental Industry Segments & Sub-Segments Performance

Based on Segment, China dental industry include Preventive Dentistry, Dental Lasers, Implants (Titanium/Zirconium), Endonotics Dentistry, Orthodontic Dentistry, Others. Preventive dentistry is dental care that helps to maintain good oral health in China. It’s a compound of regular dental check-ups along with developing good habits like flossing and brushing. Nowadays, laser dentistry is growing more popular in China. That’s because lasers can be efficiently used to handle two of the most common oral ailments: gum disease and tooth decay. Many dentists have laser tools in their facilities like traditional tools or their laser equivalents.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=china-dental-market-p.php 


Sub-segment (Dental Equipment) includes Radiology, Laser, Systems & Parts, Laboratory Machines, Hygiene Maintenance Device, and Other Equipment. The demand for radiology systems in China dental healthcare has continued to witness an upsurge due to its feature. Dental radiographs alert dentists to changes in hard and soft tissues. Radiographs enable the dentist to see how their teeth and jawbones are growing. Radiology equipment includes:

•    Intraoral x-ray systems.
•    Extraoral x-ray systems.
•    Cone-beam computed tomography imaging.
•    Intraoral plate scanners.


Furthermore, the dental laboratories primarily engage in the manufacturing and customization of various products that provide oral health care by a licensed dentist in China. These products comprise crowns, bridges, and dentures. The prime role of a dental laboratory in restorative dentistry is to copy all of the functional and esthetic parameters of the tooth, which the licensed dentist defines as a vital solution in China.


COVID-19 Pandemic Impact on Chinese Dental Market Size:

COVID-19 pandemic had a destructive impact on China dental industry. During the lockdown dental clinics were closed down. Wages and clinic rentals have to be accounted for every month despite no revenues, causing a substantial socio-economic impact. Dental doctors carried out dental procedures only in emergencies; else, they postponed the operations. This reduced the demand for dental burs and endodontic products. Moreover, manufacturing activities of dental products faced hindrances due to lockdown imposed in China. In addition, there was a shortage of raw materials and disruptions in the supply chain.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/colonoscopy-devices-market-p.php


Competitive Landscape

The China dental market has numerous players such as Sirona Dental Systems Foshan Co, Danaher, 3M Co, and Straumann, focusing on maintaining their presence. These companies continuously develop dental equipment products and widen their distribution channels across China to establish their footprints.  For instance, in 2019, Danaher established Envista Holdings, which was made up of KaVo Kerr, Nobel Biocare Systems, and Ormco – three operating companies within Danaher’s Dental segment.

  • Segments – Our Report covered by segments China Dental Market have been covered from 6 viewpoints (Preventive Dentistry, Dental Lasers, Implants (Titanium/Zirconium), Endonotics Dentistry, Orthodontic Dentistry, Others)
  • Sub-Segments (Dental Equipment) – This Report covered by Sub-Segments (Dental Equipment) China Dental Market have been covered from 6 viewpoints (Radiology, Laser, Systems & Parts, Laboratory Machines, Hygiene Maintenance Device, Other Equipment)
  • Region – Renub Research Report covered by Region China Dental Market have been covered from 4 viewpoints (Beijing, Shanghai, Guangzhou, Others)
  • All the leading players have been covered from 3 Viewpoints (Overview, Recent Developments and Revenue) Sirona Dental Systems Foshan Co, Danaher, 3M Co and Straumann

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Neonatal Intensive Care Market to Reach USD 9.9 Billion by 2027

The latest report by Renub Research “Neonatal Intensive Care Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Neonatal Intensive Care Market reached a value of USD 6.8 Billion by 2021. The neonatal intensive care unit is a specified nursery care room specifically designed for newborn babies up to 28 days in need of intensive medical care. The neonatal care units are equipped with advanced machines that provide critical care support to preterm babies with low birth weight or suffering from serious medical conditions like respiratory distress syndrome.

Global Neonatal Intensive Care Market to Reach USD 9.9 Billion by 2027

As per WHO – World Health Organisation approximately 15 million babies are born preterm every year. Apart from that, this number is surging at a great pace. Worldwide, prematurity has become one of the leading causes of death in neonate babies. And at the same time, it is likely to surge the demand for the number of neonatal intensive care units in the hospitals to assist in the proper care of newborn babies.

Recent statistic stated that, about 11% of the total pregnancies result in premature or early deliveries. Approximately 450,000 babies are born prematurely in the United States and on the globally context, around 16 million new births are early or premature stages. Further, the neonate babies that need special care and attention will often need to be admitted to specialized neonatal healthcare that has equipped with latest technologies and advanced treatment facilities. In recent years, AI intelligence into the healthcare system has played a vital role and has extended to a great extent as well as support to daily caretakers.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=neonatal-intensive-care-market-p.php

Emerging Economies to Drive Future of Neonatal Intensive Care Devices

Nevertheless, poor accessibility towards neonatal infant care in the lower-middle and low-income countries will be a major market impeding factor. In developing nations, rural and remote areas, pregnant women travel a lot of distances for deliveries of babies, thereby giving room for necessary and better treatment in the regions. Apart from that, poor infrastructure and poor-quality equipment are also the significant threats to market growth.

An increase in number of premature births across the globe will be a prominent factor augmenting the neonatal infant care market growth. Pre-term birth complications are considered the foremost cause of death among children less than 5 years of age. In low-income economies, around half of the babies are born two months early and die owing to a lack of cost-effective and basic care. Therein, in the high-income nation, almost all the pre-term babies survive.

Worldwide Neonatal Intensive Care Market Size was USD 6.8 Billion in 2021

As per our research findings; Global Neonatal Intensive Care Industry to grow with a CAGR of 6.46% during 2021-2027.

Based on Products, the market is segmented into Incubators, Neonatal Ventilators, Resuscitators, Blood Pressure Monitors, Pulse Oximeter, Capnographs, Phototherapy Equipment and others. Furthermore, the report covers on the basis of Geographical Region say North America, Europe, Asia-Pacific and Rest of World.

Apart from that, key players into the Neonatal intensive care industry are Philips, Becton, Dickinson & Company (BD), Teleflex Incorporated and Utah Medical Inc. There has been immense competition into the particular industry and to compete, the company needs to update their product differentiation and loyalty for their customers.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/neonatal-intensive-care-market-p.php

COVID-19 Impact on this Industry

The outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across the nations resulting in disruptions in import and export activities of Neonatal Intensive Care.

COVID-19 can affect the globally in three ways:

•    Directly affecting production and demand

•    Creating supply chain and market disruption

•     Financial impact on firms and financial markets

Our analysts has suggested post pandemic recovery and will definitely the market will growth at a steady pace during forecast period.

Market Summary:

Products: The global market is bifurcated into Incubators, Neonatal Ventilators, Resuscitators, Blood Pressure Monitors, Pulse Oximeter, Capnographs, Phototherapy Equipment and Others

Geographical Region: In this report we have covered regions like North America, Europe, Asia-Pacific and Rest of World)

Company: Companies covered in this report are Philips, Becton, Dickinson& Company (BD), Teleflex Incorporated and Utah Medical Inc

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on LinkedIn: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Colonoscopy Devices Industry is likely to grow with a CAGR of 6.92% during 2020-2027

As per Renub Research, report titled “Colonoscopy Devices Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Colonoscopy Devices Market is expected to be USD 2.1 Billion by 2027. Globally, Colonoscopy devices are used to examine the inside of the colon using a colonoscope inserted into the rectum. Wherein, colonoscope implies a thin, tube-like instrument with a light and a lens for viewing. Besides, a colonoscopy may also have a tool to remove tissue to be checked under a microscope for signs of disease. In addition, the gastroenterologist carefully guides the colonoscope in various directions to look inside the colon. After that, a picture from the camera appears on a monitor to provide a clear, magnified view of the colon lining.

Global Colonoscopy Devices Market to Grow at CAGR of 6.92% during 2020-2027

Identification of the Cause of Signs and Symptoms for Colorectal Cancer drives the Market:

A colonoscopy is conducted to find the reason for signs and symptoms, constituting bleeding from the rectum, blood in the stools, pus or mucus in the stools, unexplained abdominal pain, changes in bowel habits, and unexplained long-lasting diarrhoea, screening and examination for colorectal cancer. Popularly, colonoscopy across the world is used to examine for cancer of the colon (bowel cancer) or colon polyps, which are extensions on the colon lining that can seldom be cancerous or may grow to be cancerous. Remarkably, as per the World Health Organization, in 2020, colorectal cancer estimated for around 1.93 Million numbers and more than 935,000 deaths globally.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=colonoscopy-devices-market-p.php

Visualization System is Estimated to be the Dominating and Fastest-Growing Division:

By product, colonoscopy devices are segmented into Visualization systems, colonoscopes and others. Visualization system is estimated to be the dominating and fastest-growing segment due to increasing preference for HD visualization systems. Besides, Visualization systems are popular among medical professionals, as they efficiently help in the examination & operation of complex disorders such as Colorectal cancer, Lynch syndrome, Ulcerative colitis, and others. Besides, colonoscope devices are employed to recognize lesions in the proximal perspective of colonic folds either by proffering a retrograde appearance of the lumen or straightening the haustral folds during withdrawal. Associated benefits of colonoscopy over other treatment options, such as enhanced precision, accuracy, and medication safety, are expected to boost its demand in surgical centres.

Hospitals Emerged as the Largest End-User Segment:

Hospitals are the primary health system constituting the usage of colonoscopy devices globally. The abundance of colorectal surgeries undertaken at hospitals is comparatively higher than the other health systems, such as clinics, ambulatory surgical centres (ASCs) or others. Consequently, the demand for colonoscopy devices in hospitals is relatively higher than that in other end-use segments.

North America Rules the Market and is anticipated to continue to do the same during the Forecast Period:

Currently, North America dominates the market for colonoscopy devices, and it is expected to continue its stronghold during the forecasted period. Key factors accountable for its dominance are increased treatment rates, high incidence of colorectal cancer in the region, inflated medicine prices compared to other major regions like Europe, Asia Pacific, South America and Middle East& Africa. In addition, the high unmet clinical needs of patients in the areas of North America, such as the lower Mississippi Delta and parts of Appalachia in the United States, are also boosting the market growth. Furthermore, growing healthcare investment and the well-established healthcare foundation are also fuelling the development of the overall regional market to a large extent.

Major Players in the Competitive Panorama:

The market is profoundly competitive and consists of several global players. As the industry progresses, the firms try to achieve clear differentiation in colonoscopy systems based on their application. Due to high-quality imaging and operative capabilities requirements, various customer groups are shifting toward optimized visualization systems that integrate colonoscopes and cameras. Some of the companies currently present in the market are Boston Scientific Corporation, Medtronic, Steris Plc, Olympus and Hoya. For instance, in April 2021, Medtronic launched an AI-based colonoscopy device in the US on the heels of FDA clearance.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/colonoscopy-devices-market-p.php

Impact of COVID-19 on Colonoscopy Devices Industry:

COVID-19 pandemic had an immediate influence on the colonoscopy healthcare industry. Colonoscopy, the backbone for the diagnosis & administration of colorectal cancer, has come under tension due to COVID-19 in 2020. All non-urgent methods have been either rescheduled or substituted by replacement biomarkers. The pandemic was the chief reason for the slump of the market for colonoscopy devices in 2020. However, in 2021, the market has rebounded with double percentage maturity.

Market Summary:

  • By Product: We have covered Visualization system, Colonoscope and Others as major variants existing in the industry.
  • By Application: We have studied the application of Colonoscopy Devices in Colorectal cancer, Lynch syndrome, Ulcerative colitis and other.
  • By End User: We have covered Hospitals, Clinic, Ambulatory surgery center and others as end users.
  • By Region: We have analysed the Colonoscopy Devices industry in North America, Asia Pacific, Europe, Latin America, Middle East & Africa.
  • Company Analysis: In our report market’s main players studied includeBoston Scientific Corporation, Medtronic, Steris Plc, Olympus and Hoya.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Sleep Apnea Devices Market by Device Type, Companies, Forecast

According to the latest report by Renub Research, titled “Sleep Apnea Devices Market, Global Forecast, Impact of COVID-19, Industry Trends by Device Type, Opportunity Company Overview, Revenue” the Sleep Apnea Devices Market is expected to reach US$ 8.7 Billion by 2027. Sleep apnea is a disorder distinguished by rhythmic and repetitive obstruction of the upper airway provoking pharyngeal collapse. During sleep apnea disorder, breathing is repeatedly interrupted during sleep; these breathing pauses typically last between 10 to 20 seconds and happen from 5 to over 100 times per hour. There are three main characters of sleep apnea obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Sleep apnea therapy aims to open the airway and breathe better at night. Many devices help that happen.

Key Market Trends:

  • The expanding prevalence of (OSA) obstructive sleep apnea disorder, complex sleep apnea syndrome and central sleep apnea are among the key factors driving the growth of the Sleep apnea device industry. Such conditions are highly prevalent among the geriatric and population suffering from other ailments, such as hypertension and cardiovascular diseases (CVDs) and diabetes, facilitating product adoption across developed and emerging nations.
  • According to Respirology, 1 billion of the world’s population of 7.3 billion people, between the ages of 30 and 69 years, has the most common Type of sleep-disordered breathing, obstructive sleep apnoea (OSA).
  • As a result of rising life anticipation, the growing geriatric population increases the prevalence of sleep disease. With the development of the geriatric population, the usage of Sleep apnea devices will increase, as the senior population is more prone to sleep apnea devices.
  • As per WHO (World Health Organization), in 2018, the world’s population of people aged 60 and above will reach 2.0 billion by 2050.
  • In 2021, the FDA announces the approval of a prescription tongue muscle stimulation device that claims to defeat mild obstructive sleep apnea (OSA) and to snore. The device, named eXciteOSA, is pass through the de novo regulatory pathway for people 18 years and older.


Worldwide Sleep Apnea Device Market Size was US$ 5.2 Billion in 2020

On the basis of Type, Sleep apnea appliances industry includes therapeutic devices and diagnostic devices. Sleep apnea therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Auto CPAP Sleep Apnea machines. The (CPAP) continuous positive airway pressure unit is the most prescribed machine for sleep apnea. Auto CPAP Sleep Apnea machines are used to evaluate the patient’s respiratory and other bodily functions during sleep.


Apart from this, sleep apnea diagnostics devices are segmented into Polysomnography Devices (PSG), Respiratory Polygraph, Sleep Apnea Screening Devices, Oximeter, and Actigraphy Monitoring Device.  Pornographically Devices (PSG), attributed to the fact that it is a multi-parameter study that records patient’s brain waves, heart rate and breathing, the oxygen level in the blood, and even eye and leg movements during the diagnosis procedure.


Moreover, diagnostic devices, clinical PSG devices, pulse oximeters, and heart–rate systems make up most of the devices used in sleep hospitals and laboratories worldwide. The number of sleep tests performed and sleep laboratories with a clinical polysomnography device are increasing. These tests are promptly regarded as the regular diagnostic test for sleep apnea.


North America is Driving the Demand of Sleep Apnea Devices Industry

Among different regions, the increasing prevalence of respiratory illnesses in North America is causing sleeping disorders, boosting the demand for Sleep apnea devices. The United States operates the majority of the sleep apnea devices market in North America. According to the American Sleep Association, in 2018, 50-70 million adult populations in the United States were found to have a sleep disorder.


Furthermore, a huge patient pool, raising awareness of sleep apnea, and the presence of foreign manufacturers are boosting the demand for Sleep apnea devices in Europe. The abundance of diagnostic tests for proving the presence of sleep apnea in the region is fast increasing, as numerous people are concerned about the health concerns associated with this illness.


COVID-19 Pandemic Impact on Sleep Apnea Devices Market:

The COVID-19 pandemic affects the management of sleep apnea patients. Physical isolation, social distancing, and suspension of many clinical services complicate the already prevalent underdiagnosis of sleep disorders and potentially delay treatment for those diagnosed. Sleep Apnea Devices companies faced specific operational and logistic challenges due to the imposition of nationwide lockdowns.

Competitive Landscape:

The sleep apnea devices market is highly competitive, with several major players such as Summoned, Resmed, Koninklijke Philips N.V., Carefusion Corp. (Part of Becton, Dickinson and Company), Imthera Medical, Inc. (Part of Livanova Plc) across the world.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=sleep-apnea-devices-market-p.php


Market Summary

  • Type – Renub Research Report covered by Type in the Sleep Apnea Devices Market breakup by 2 viewpoints (Therapeutic Devices, Diagnostic Devices)
  • Therapeutic Devices – Sleep Apnea Devices Market have been further sub-segmented from 4 viewpoints: (CPAP Sleep Apnea, Auto CPAP Sleep Apnea, BiPAP Sleep Apnea, Others)
  • Diagnostic Devices – Sleep Apnea Devices Market have been further sub-segmented from 5 viewpoints: (Polysomnography Devices (PSG), Respiratory Polygraph, Sleep Apnea Screening Devices, Oximeter, and Actigraphy Monitoring Device)
  • End-User – Our Report covered by End User Sleep Apnea Devices Market breakup by 2 viewpoints (Sleep Laboratories & Hospitals & Home Care Setting/Individuals)
  • Region – This Report covered by Region Sleep Apnea Devices Market breakup by 4 viewpoints (North America, Europe, Asia Pacific, ROW)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Developments and Revenue) Summoned, Resmed, Koninklijke Philips N.V., Carefusion Corp. (Part of Becton, Dickinson and Company), Imthera Medical, Inc. (Part of Livanova Plc)

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Genetic Testing Market to Grow at 9.6% CAGR during 2021-2027, Impelled by Increasing Burden of Cancers Worldwide

According to the latest report by Renub Research, titled “Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Genetic Testing Market is expected to reach US$ 25.05 Billion by 2027. Genetic testing plays an essential role in diagnosing the carrier detection disease, presymptomatic, and prenatal diagnosis. As per the (WHO) World Health Organization, 10,000 diseases worldwide are monogenetic, created by modification or variation in a single gene present in every single cell of a body; those diseases can only be diagnosed and prevented by genetic testing.

Global Genetic Testing Market to Grow at 9.6% CAGR during 2021-2027

Moreover, genetic testing is a form of medical testing performed to identify any changes in the DNA sequence or chromosome structure. Genetic testing practices are rapidly progressing in rare disease diagnostics and personalized medicine. There are different kinds of tests practiced in examining genetic disorders like Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, and others. These tests are used to diagnose medical conditions such as genetic disease, cancer diagnosis, diagnosis, and cardiovascular disease diagnosis.


Globally New Cancer Cases were more than 19 Million and Deaths from Cancer were also more than 9 Million

The increasing burden of cancers worldwide and the growing awareness among the global population on predictive testing and personalized medicine are the major factors that demand genetic testing in cancer. Thus, the aid of the genetic test provides information on whether cancer runs in the family and the risk factors connected with the development of cancers in future among the individuals with a family history of diseases. Also, genetic testing is conducted in patients who do not respond to chemotherapy to identify the presence of acquired mutations in tumors that are resistant to therapy. By Globocan 2020, the rate of new cancer cases was 19,292,789, with nearly 9,958,133 deaths due to cancers.


Genetic testing includes cytogenetic, biochemical, and molecular testing based on technology. Molecular testing is the most standard technology for genetic testing. For instance, molecular technology is used in genetic tests such as diagnostic, carrier, predictive, & presymptomatic testing, etc. Furthermore, molecular testing is also favored as it can be applied to analyze gains or losses in DNA that are not detectable with regular chromosome analysis.


United States New Cancer Cases were more than 2 Million and Deaths from Cancer were also more than 0.6 Million

Geographically, North America runs the market for genetic testing by advancements in technology in the genetic testing space. The growth in the ageing population, a subsequent rise in the cases of chronic diseases, and rising cancer cases are a few factors aiding the demand for genetic testing in the region. For instance, in 2020, by Globocan, in the US, among all cancers, breast cancer had the highest incidence, followed by lung prostate and colon. The new cancer cases diagnosed were 2,281,658 in the United States, with 612,390 deaths.


On the one hand, there is a massive demand for genetic testing in Asia-Pacific due to increased affordability, the surge in healthcare expenditure, and the rise in awareness toward early screening of genetic disorders. In the future, the Asia-Pacific Genetic Testing Market Size will be more than double.


Covid-19 Impact on Genetic Testing Market

COVID-19 pandemic has also affected the genetic testing market adversely. After the WHO declared COVID-19, worldwide adopted lockdowns to observe social distancing to contain the spread. The pandemic hurts the genetic testing market. This is attributed to the point that genetic counselors cannot see patients in person, laboratories cannot run the tests, and doctors are not available for counselling. In addition, governmental bodies such as the Centers for Medicaid Services (CMS) presently do not recognize genetic counselors as healthcare providers. Hence, they are not exempted from training during lockdowns.

The global genetic testing industry is highly ambitious, and the prominent players in the market have adopted several strategies to garner maximum genetic testing market share. These include product launch, collaboration, partnership, and acquisition. Key players operating in the genetic testing market include Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=genetic-testing-market-p.php

  • Type – We have covered by type in the Genetic testing market breakup by 7 viewpoints (Predictive Testing, Carrier Testing, Prenatal and New-born Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing and Others)
  • Technology – Renub Research Report covers by technology in the Genetic testing market breakup by 3 viewpoints (Cytogenetic Testing, Biochemical Testing and Molecular Testing)
  • Application – This Report covered by application in the Genetic testing market breakup by 3 viewpoints (Cancer, Genetic Diseases, Cardiovascular Diseases and Others)
  • Region – Our Report covered by region in Genetic testing market breakup by 4 viewpoints (Europe, America, Middle East & Africa and Asia-Pacific)
  • All the key players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue) Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Precision Irrigation Market will grow with a CAGR of 9.57% during 2020-2027

Precision Irrigation is gaining tremendous popularity among farmers due to the increasing need for optimum crop production with limited available resources. Precision Irrigation is one of the innovative techniques that uses water wisely and helps farmers achieve higher crop yield levels in a minimal amount of water. Precision farming can transform the agricultural sector, making the traditional farming activity more efficient and predictable.

Precision Irrigation Market Global Forecast 2021-2027


Further, extended profitability and crop yield, increasing global food demand, and crop health monitoring for higher yield production are the significant factors fueling the growth of the precision Irrigation market. Also, government ambitions in many countries are helping farmers to use optimized agricultural and technological tools to improve their production levels. According to Renub Research Report, Precision Irrigation Market will grow with a CAGR of 9.57% during 2020-2027.


Precision Irrigation Market will grow to US$ 16.44 Billion by 2027

Based on application, the Precision Irrigation market includes Agricultural Fields, Landscape & Turf Irrigation, Greenhouse, Residential and others. Precision irrigation is defined as applying a specific amount of water at the right time and in appropriate agricultural fields. It is a section of precision agriculture that further includes seeding, variable-rate nutrients and pesticide application.


Moreover, drip irrigation is essential for controlling soil moisture, especially in the case of specialized greenhouse vegetables. Total automation of drip irrigation systems provides a simple, meticulous method for maintaining soil moisture and applying water. Effective time management, elimination of human errors, estimation, and adjusting available soil moisture levels are factors growing the demand for automatic drip irrigation systems.


Precision Irrigation Market Size was US$ 8.67 Billion in 2020

Precision Irrigation manages temporal and spatial variability of crops like Field Crops, Vegetable corps, Orchard Crops, Vineyards and Other Crops. Precision agriculture was used in handpicked fruit orchards crops includes citrus, almonds, avocados, vineyards, apples, peaches, etc. Besides, the demand for vegetable crops is continuously increasing. Precision irrigation is among the most modern technologies for sustainable vegetable crops; as vegetable crops require ample amounts of water, farmers switch to sprinkler and drip irrigation systems to achieve higher crop productivity. Thus, increasing production of vegetable crops is demanded Precision irrigation.


Regional Insights: Precision is getting popular in Europe & Gulf Cooperation Council (GCC) Countries

Precision sprinkling systems are gaining immense popularity in Europe, particularly in countries, like the United Kingdom and Germany. The U.K. was the first to appropriate precision irrigation, with France and Germany also rapidly adopting this technology. There is a vast potential for precision irrigation in the GCC, which invests heavily in innovative solutions to boost crop production by overcoming water scarcity.


Aside from Europe and Asia-Pacific, North America is the key region for precision irrigation systems. Countries such as U.S. and Canada, the Americas are the early adopters of precision farming technologies, which is the main reason for the high share of this region in the precision farming market.


Impact of COVID-19 on Precision Irrigation System

The Precision Irrigation market is expected to witness a marginal dip in 2020 due to the COVID-19 pandemic. The movement restriction and lockdowns have resulted in disruptions in the supply chain and led to a shortage of equipment. However, remote sensing and farm management software tools could lead to higher adoption during the post-COVID-19 period.


Renub Research latest Report “Precision Irrigation Market, Global Forecast, By Type (Drip Irrigation, Sprinkler Irrigation and Others), Application (Agricultural Fields, Landscape and Turf Irrigation, Greenhouse, Residential and others), Crop (Field Crops, Vegetable corps, Orchard Crops, Vineyards and Other Crops), Region (North America, Europe, Asia- Pacific, South America, Rest of World), Company Analysis (Jain Irrigation Systems Ltd, Lindsay Corporation, The Toro Company and Valmont) )” studies the Precision Irrigation Industry.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=precision-irrigation-market-p.php


Type – Precision Irrigation Market breakup from 3 viewpoints

1.    Drip Irrigation
2.    Sprinkler Irrigation
3.    Others


Application – Precision Irrigation Market breakup from 5 viewpoints

1.    Agricultural Fields
2.    Landscape and Turf Irrigation
3.    Greenhouse
4.    Residential
5.    Others


Crop– Precision Irrigation Market breakup from 5 viewpoints

1.    Field Crops
2.    Vegetable corps
3.    Orchard Crops
4.    Vineyards
5.    Other Crops


Region – Precision Irrigation Market breakup from 5 viewpoints

1.    North America
2.    Europe
3.    Asia Pacific
4.    South America
5.    Rest of World


All key players have been covered from 3 viewpoints

•    Overviews
•    Recent Developments
•    Revenues


Company Analysis

1.    Jain Irrigation Systems Ltd
2.    Lindsay Corporation
3.    The Toro Company
4.    Valmont

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Webhttps://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Colonoscopy Devices Industry is likely to grow with a CAGR of 6.92% during 2020-2027

Colonoscopy devices are the gold standard for colorectal cancer prevention. Worldwide colorectal cancer is the third most common cancer diagnosed in both men and women each year. According to the World Health Organization, in 2020, colorectal cancer accounts for around 1.93 Million incidences and more than 935,000 deaths globally. Further, colonoscopy devices are the endoscopic test of the distal part of the small bowel and the large bowel by fibre optic camera or a CCD camera on a flexible tube passed through the anus. It allows proper diagnosis and treatment without the need for a significant operation. As per Renub Research, Colonoscopy Devices Market is project to reach US$ 2,031.96 Million by 2027.

Factors Driving Colonoscopy Devices Demand Globally

The vital factors driving the market growth include the expanding preference for minimally invasive techniques, the growing prevalence of colorectal cancer, and technological advancements. Upcoming launches of promising pipeline applicants, the emergence of more front-line therapies, and favorable government initiatives are likely to fuel market expansion.


Visualization System is estimated to be the Fastest-growing Segment

Based on product, colonoscopy devices are segmented into Visualization systems, Colonoscope and others. Visualization system is estimated to be the fastest-growing segment due to increasing preference for HD visualization systems. It is popular among medical professionals, as they help in the diagnosis & treatment of complex diseases such as Colorectal cancer, Lynch syndrome, Ulcerative colitis, and others. Moreover, colonoscope devices are utilized to identify lesions in the proximal aspect of colonic folds either by giving a retrograde view of the lumen or straightening the haustral folds during withdrawal.


Hospitals Emerged as the Largest End-User Segment

Besides, hospitals are the primary health system globally. The number of colorectal surgeries undertaken at hospitals is comparatively higher than the other health systems, such as clinics, ambulatory surgical centers (ASCs) or others. Therefore, the demand for colonoscopy devices in hospitals is comparatively higher than that in other end-use segments.


Global Colonoscopy Devices Market Size was US$ 1,271.95 Million in 2020

The United States has the most comprehensive market for colonoscopy devices in North America; the increase in treatment rates, rising healthcare expenditure, and well-established healthcare infrastructure fuel the demand for colonoscopy devices. In addition, high incidence of colorectal cancer is to be the leading cause of cancer deaths in the United States; as per the National Center for Health Statistics, in 2020, 147,950 individuals diagnosed with CRC and 53,200 has died from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years.


Impact of COVID-19 on Colonoscopy Devices Industry

COVID-19 pandemic had a direct impact on the colonoscopy healthcare market. Colonoscopy, the mainstay for the diagnosis & management of colorectal cancer, has come under pressure due to COVID-19 in the year 2020. All non-urgent procedures have been either rescheduled or replaced by alternative biomarkers. This was the main reason for the decline of the market for colonoscopy devices in the year 2020. But in 2021, the market has rebounded with double percentage growth.

Colonoscopy Devices Industry is likely to grow with a CAGR of 6.92% during 2020-2027

The colonoscopy devices industry is moderately competitive and consists of several global players such as Boston Scientific Corporation, Medtronic, Steris Plc, Olympus and Hoya. Mergers & acquisitions, high investments in R&D, and new product developments or modifications are among the key strategies players adopt to gain a competitive edge.


Renub Research latest report “Colonoscopy Devices Market By Product (Visualization system, Colonoscope and Others), Application (Colorectal cancer, Lynch syndrome, Ulcerative colitis and other), End User (Hospitals, Clinic, Ambulatory surgery center and others), Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), Company Analysis (Boston Scientific Corporation, Medtronic, Steris Plc, Olympus and Hoya)” provides comprehensive details about Colonoscopy Devices Industry.


Product – Market breakup from 3 viewpoints

1.    Visualization system
2.    Colonoscope
3.    Others


Application – Market breakup from 4 viewpoints

1.    Colorectal cancer
2.    Lynch syndrome
3.    Ulcerative colitis
4.    Other


End User – Market breakup from 4 viewpoints

1.    Hospitals
2.    Clinic
3.    Ambulatory surgery center
4.    Others


Region – Market breakup from 5 viewpoints

1.    North America
2.    Europe
3.    Asia Pacific
4.    Latin America
5.    Middle East & Africa


All companies have been covered into 3 viewpoints

• Overviews
• Recent Developments
• Revenues


Company Analysis

1.    Boston Scientific Corporation
2.    Medtronic
3.    Steris Plc
4.    Olympus
5.    Hoya

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research